- Sector
- Health services
- Industry
- Services to the health industry
- Address
- Cairo Egypt
- IPO Date
- Jul 28, 1999
- Business
- The Holding Company for Financial Investment - The Lakah Group is an Egypt-based diversified holding company primarily engaged in healthcare infrastructure development, medical equipment supply, industrial manufacturing, and non-banking financial investments. Established as a joint-stock holding company in 1998 with origins in medical and commercial trading enterprises, the company is headquartered in Heliopolis, Cairo, Egypt, and conducts its business operations across Egypt and the wider Middle East and North Africa region. The company operates through a portfolio of specialized subsidiaries and core business divisions, providing a comprehensive range of products and services: healthcare facility contracting and turnkey hospital development, including architectural planning, construction, room outfitting, and biomedical engineering; supply, distribution, and maintenance of medical technologies, diagnostic imaging equipment, surgical systems, laboratory instruments, and clinical consumables; manufacturing and wholesale distribution of industrial chemical goods, commercial detergents, and cleaning products; and diversified financial operations comprising non-banking financial services, equity portfolio management, corporate restructuring, and capital allocations. The group has historically engineered and equipped more than twenty premier medical centers, including Dar Al Fouad Hospital, the Nasser Institute, Al Salam Hospital, Luxor Hospital, and Sharm El Sheikh International Hospital.
In recent developments, The Holding Company for Financial Investment - The Lakah Group has executed a series of major operational, strategic, and corporate reorganizations designed to re-establish market leadership and maximize shareholder value. Following the resolution of long-standing credit negotiations and the receipt of final liability clearance certificates from major institutional lenders, including Banque Misr, the company reorganized its executive leadership and elected a renewed board of directors under the leadership of Chairman Rami Raymond Michel Lakah, with regulatory ratification from the Financial Regulatory Authority and the General Authority for Investment and Free Zones. Furthermore, the company has successfully approved audited financial statements reflecting renewed operational revenue and profitability, authorized bonus share distributions to reinforce its capitalization structure, and transitioned its equity trading mechanism on the Egyptian Exchange to the automated order-matching system. Strategically, the company continues to expand its pipeline of healthcare infrastructure projects, upgrade its medical technology distribution networks, and deploy capital into high-growth non-banking financial and industrial opportunities.